Anthony Vendetti
Stock Analyst at Maxim Group
(4.12)
# 575
Out of 4,667 analysts
69
Total ratings
29.41%
Success rate
32.66%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Maintains: Buy | $22 → $8 | $2.53 | +216.21% | 1 | Nov 15, 2024 | |
| SRTS Sensus Healthcare | Maintains: Buy | $12 → $14 | $8.94 | +56.60% | 5 | Nov 15, 2024 | |
| NUTX Nutex Health | Maintains: Buy | $45 → $50 | $30.33 | +64.85% | 2 | Nov 12, 2024 | |
| HSDT Helius Medical Technologies | Downgrades: Hold | n/a | $0.45 | - | 2 | Oct 16, 2024 | |
| NXL Nexalin Technology | Initiates: Buy | $3 | $3.80 | -21.05% | 1 | Oct 9, 2024 | |
| CELH Celsius Holdings | Maintains: Buy | $65 → $50 | $27.71 | +80.44% | 7 | Sep 5, 2024 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $10 → $6 | $1.16 | +417.24% | 3 | Aug 21, 2024 | |
| BIAF bioAffinity Technologies | Initiates: Buy | $6 | $1.27 | +372.44% | 1 | Jul 23, 2024 | |
| RSLS ReShape Lifesciences | Downgrades: Hold | n/a | $5.04 | - | 2 | Jul 17, 2024 | |
| HAIN The Hain Celestial Group | Maintains: Buy | $18 → $15 | $7.42 | +102.16% | 6 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.86 | +601.75% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $8.44 | +18.48% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.33 | +114.59% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.45 | +561.96% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.35 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $4.92 | -59.35% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $2.15 | +5,713.95% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $1.58 | +343.04% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.30 | - | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $51.53 | -51.48% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $7 | $1.52 | +360.53% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.30 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $140 | $0.16 | +89,874.29% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $2.95 | +69.49% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.39 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.60 | +397.93% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $16.14 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $0.18 | +27,110.88% | 1 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $160 | $0.17 | +96,869.70% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $47.39 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $0.84 | +85,583.68% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.09 | -50.45% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.33 | - | 1 | May 31, 2016 |
Tenon Medical
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $2.53
Upside: +216.21%
Sensus Healthcare
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $8.94
Upside: +56.60%
Nutex Health
Nov 12, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $30.33
Upside: +64.85%
Helius Medical Technologies
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.45
Upside: -
Nexalin Technology
Oct 9, 2024
Initiates: Buy
Price Target: $3
Current: $3.80
Upside: -21.05%
Celsius Holdings
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $27.71
Upside: +80.44%
Dermata Therapeutics
Aug 21, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $1.16
Upside: +417.24%
bioAffinity Technologies
Jul 23, 2024
Initiates: Buy
Price Target: $6
Current: $1.27
Upside: +372.44%
ReShape Lifesciences
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.04
Upside: -
The Hain Celestial Group
May 9, 2024
Maintains: Buy
Price Target: $18 → $15
Current: $7.42
Upside: +102.16%
Jan 30, 2024
Initiates: Buy
Price Target: $6
Current: $0.86
Upside: +601.75%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $8.44
Upside: +18.48%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $2.33
Upside: +114.59%
Oct 5, 2023
Initiates: Buy
Price Target: $3
Current: $0.45
Upside: +561.96%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.35
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $4.92
Upside: -59.35%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $2.15
Upside: +5,713.95%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $1.58
Upside: +343.04%
Mar 30, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.30
Upside: -
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $51.53
Upside: -51.48%
Mar 29, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $1.52
Upside: +360.53%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.30
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $240 → $140
Current: $0.16
Upside: +89,874.29%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $2.95
Upside: +69.49%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.39
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $0.60
Upside: +397.93%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $16.14
Upside: -
Jul 6, 2022
Initiates: Buy
Price Target: $48
Current: $0.18
Upside: +27,110.88%
Nov 22, 2019
Upgrades: Buy
Price Target: $160
Current: $0.17
Upside: +96,869.70%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $47.39
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $0.84
Upside: +85,583.68%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.09
Upside: -50.45%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $0.33
Upside: -